Silicos expands biology lab and announces move to new facilities
Drug development biotech further extends its computational fragment based drug design efforts with increased biology lab
30-Jul-2009 -
Silicos NV, a Belgian biotech focusing on computational fragment based drug discovery, announced that it is taking several steps to increase its biological lab capabilities. First of all, Silicos has further strengthened its team to increase the capacity to screen compounds identified by Silicos ...
Belgium
biology
drug development
+1